Key points are not available for this paper at this time.
The results show that the fully magnetically levitated centrifugal-flow chronic LVAS is safe, with high 30-day and 6-month survival rates, a favorable adverse event profile, and improved quality of life and functional status. (HeartMate 3™ CE Mark Clinical Investigation Plan HM3 CE Mark; NCT02170363).
Netuka et al. (Tue,) studied this question.